Office of Research & Development

VA RESEARCH QUARTERLY UPDATE
 

Honorable Mentions

Gene therapist receives Magnuson award


Dr. David Fink

Dr. David Fink

Gene therapy pioneer and longtime VA researcher Dr. David Fink received the 2014 Paul B. Magnuson Award in a ceremony at the VA Ann Arbor Healthcare System on Dec. 15, 2014. Fink, who has been with VA since 1982, is a staff neurologist and an investigator with the Ann Arbor VA's GRECC whose work has led to discoveries that alleviate pain in Veterans. He is also the Robert Brear Professor and Chair of Neurology at the University of Michigan.

Fink has pioneered methods to introduce genes into the body to treat chronic pain and other nervous-system diseases. His team led the first human clinical trial of gene therapy for pain, on a group of cancer patients with severe pain that had failed to respond even to high doses of morphine. The trial was successful, and a larger trial of the approach is now being planned. Besides cancer pain, his work has also focused on reducing pain in Veterans and others with nerve-related conditions such as spinal cord injury and diabetic neuropathy.

The Magnuson award honors the life and legacy of Dr. Paul B. Magnuson, who as a bone and joint surgeon continuously sought new treatments and devices for assisting his patients as they faced unique situations presented by their disability. The award is presented annually to a VA investigator who exemplifies the entrepreneurship, humanitarianism, and dedication to Veterans that Magnuson displayed.


Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.